| Current Price | $1.40 | Mkt Cap | $1.1B |
|---|---|---|---|
| Open | $1.37 | P/E Ratio | -3.54 |
| Prev. Close | $1.40 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $1.34 - $1.41 | Volume | 1,980,202 |
| 52-Wk Range | $1.00 - $3.11 | Avg. Daily Vol. | 3,090,182 |
| Current Price | $1.40 | Mkt Cap | $1.1B |
|---|---|---|---|
| Open | $1.37 | P/E Ratio | -3.54 |
| Prev. Close | $1.40 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $1.34 - $1.41 | Volume | 1,980,202 |
| 52-Wk Range | $1.00 - $3.11 | Avg. Daily Vol. | 3,090,182 |
The best Bull and Bear pitches based on recency and number of recommendations.
Their 4KScore Test accurately predicts prostate cancer risk has received insurance classificationTheir drug Rayaldee with a +$10B market potential completed phase 3 trials and an NDA was submitted to to the FDA last May we approval expect in… More
Uses known stock promoter Redchip.com. Is a pump and dump scam.
Read the most recent pitches from players about OPK.
Recs
Hermanator
(< 20)
Submitted: 2/28/2021 7:02:46 PM :
Start Price:
$4.57
NASDAQ:OPK Score:
-78.98
COVID NOT GOING TO VR A FACTOR IN 5 years
Recs
TMFbonefish
(35.14)
Submitted: 1/12/2021 7:10:56 PM :
Start Price:
$4.33
NASDAQ:OPK Score:
+79.28
COVID has created an opportunity for this company to dissolve itself and do right by shareholders. I don't think they will do it. The testing business will be commoditized and I don't see any breakthroughs on the drug side of the business.
Recs
Jerad
(< 20)
Submitted: 10/13/2020 10:58:37 PM :
Start Price:
$3.08
NASDAQ:OPK Score:
-71.58
Undervalued.
Find the members with the highest scoring picks in OPK.
avatre (< 20) Score: +370.89
The Score Leader is the player with the highest score across all their picks in OPK.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| avatre | < 20 | 6/15/2009 |
|
5Y | $1.68 | -17.26% | +353.62% | +370.89 | 0 Comment | |
| gmxBatteringRam | 27.12 | 8/5/2009 |
|
5Y | $2.05 | -32.20% | +324.09% | +356.29 | 0 Comment | |
| goldminingXpert | 27.56 | 6/15/2010 |
|
5Y | $2.06 | -32.52% | +281.05% | +313.57 | 1 Comment | |
| haimp | 26.60 | 10/7/2010 |
|
5Y | $2.31 | -39.83% | +264.11% | +303.94 | 0 Comment | |
| EcoUSA | 93.59 | 11/12/2010 |
|
5Y | $2.95 | -52.88% | +249.13% | +302.01 | 0 Comment | |
| shorttest4 | 31.15 | 3/8/2010 |
|
5Y | $2.06 | -32.52% | +269.18% | +301.70 | 0 Comment | |
| Covestor | 69.32 | 3/14/2011 |
|
NS | $3.76 | -63.03% | +225.10% | +288.13 | 1 Comment | |
| XMFConnor | 82.00 | 5/16/2012 |
|
5Y | $4.62 | -69.91% | +214.93% | +284.85 | 0 Comment | |
| stratisticalarb | 31.18 | 4/26/2011 |
|
1Y | $3.99 | -65.17% | +213.02% | +278.18 | 0 Comment | |
| nearo | < 20 | 8/1/2008 |
|
3M | $1.82 | -23.63% | +245.90% | +269.52 | 1 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
